Contrave ER 8-90 MG tablet 120S

Ended Awarded

Contract number
SPE2DB25FQJXT
Awardee
Awarding agency
Obligated
$12,921

Award facts

Contract value 100% obligated
$12,921.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $12,921.08 under a firm fixed-price contract. The award is non-set-aside and represents a child contract derived from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The SPE2DX prime vendor contract enables the company to supply a comprehensive range of pharmaceuticals and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Contrave, an obesity management medication, exemplifies the company's role in fulfilling federal healthcare supply needs through competitively awarded contracts with fixed pricing structures.

Quick answers

Who was awarded contract SPE2DB25FQJXT?

SPE2DB25FQJXT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.

How much is contract SPE2DB25FQJXT worth?

The government has obligated $12,921 on SPE2DB25FQJXT.

Is contract SPE2DB25FQJXT an order under another contract?

Yes. SPE2DB25FQJXT is a delivery order under SPE2DB25D3005, an indefinite delivery contract.

Was contract SPE2DB25FQJXT competed?

The extent of competition for SPE2DB25FQJXT was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award